Atlas FDA

Intellis Spinal Cord Stimulation Systems; Specify and Vectris Spinal Cord Stimulation Leads; Injex lead anchors

FDA premarket approval P840001/S480 · decided 2021-03-05

Approval details

PMA number
P840001
Supplement
S480
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Intellis Spinal Cord Stimulation Systems; Specify and Vectris Spinal Cord Stimulation Leads; Injex lead anchors
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Medtronic Neuromodulation
Date received
2020-12-07
Decision date
2021-03-05
Days to decision
88 days
Decision code
APPR
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Minneapolis, MN
Statement
Approval for an update to the Clinical Summary manual for Medtronic Spinal Cord Stimulation (SCS) Therapy to include data from a post-market randomized controlled trial (RCT) entitled Stimgenics Open-Label, Post Market Study: A Clinical Trial to Study the Effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) Programs in Treating Intractable Chronic Back Pain. There are no changes to indications for use, procedures or devices.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23